The rocky 2020 markets led to a partial v-shaped recovery. Covid-19 plays like Moderna $MRNA more than quadrupled. But the $SPY is still erasing the year's losses and the tech sector $QQQ is up YTD.Two biotech picks for June are Moderna $MRNA again.Moderna's Phase 2 study is underway and could yield good results.Regeneron $REGN is at NEW highs:Both stocks are DIY SUBSCRIPTION picks in the last 6 - 18 months.Now, add REGN and MRNA stock to T2bF on Monday.